TRANSGENE BIOTEK LTD.

TRABI

Small Cap | Healthcare
₹3.29
+0.22 (+7.16%)

Stock price as on 07 Jul 2026 at 10:46 AM

Transgene biotek ltd. share price update

As of the latest trading session, Transgene Biotek Ltd. share price is currently at ₹3.29, which is up by ₹0.22 from its previous closing. Today the s...

Transgene Biotek Ltd. stock performance

Today’s low

₹3.01

Today’s high

₹3.32

₹3.29

52 week low

₹1.83

52 week high

₹5.26

₹3.29
Open
₹3.01
Previous close
₹3.07
Share volume
77,082
Total traded value (Lakh)
₹2.36
Upper circuit
₹3.68
Lower circuit
₹2.46

Transgene Biotek Ltd. fundamentals

Market cap (Cr)
₹23.30
P/E ratio (TTM)
-13.45
Book value per share
-₹1.21
Beta
1.15
Return on equity
0%
Earnings per share (TTM)
₹0.00
Dividend yield
0%
Net profit/quarter (Cr)
-₹0.46

Transgene Biotek Ltd. technical summary

₹3.15
+ 6.41 ▲
3
Bearish
13
Bullish
5 Day3
10 Day3
12 Day3
20 Day3
26 Day3
50 Day3
100 Day3
200 Day3.3
5 Day3
10 Day3
12 Day3
20 Day3
26 Day3
50 Day3
100 Day3.5
200 Day3.1

3.03

PIVOT

First support
₹2.96
First resistance
₹3.11
Second support
₹2.88
Second resistance
₹3.18
Third support
₹2.81
Third resistance
₹3.26
RSI
46.25
ADX
26.17
MACD
0
Williams % R
-80
Commodity Channel Index (CCI)
-53.53
Date
03 Jul 2026
Same day
5,520
Week
11,687
Month
18,447
1 year
1.16
3 years
0.58
Over 1 month
-2.31%
Over 1 year
-37.42%
Over 3 months
32.73%
Over 3 years
-11.77%
Over 6 months
0.33%
Over 6 years
-8.27%

Investment Returns

Over 1 Month2.31%
Over 3 Months32.73%
Over 6 Months0.33%
Over 1 Year37.42%

Transgene Biotek Ltd. Shareholding pattern


Public
76.36%
Promoter holdings
23.63%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Dr K Koteswara Rao

1,52,11,902 (21.89%)

Shareholding of Promoter and Promoter Group

Kollipara Nirmala

11,92,000 (1.72%)

Shareholding of Promoter and Promoter Group

Kollipara Srinivas

24,000 (0.03%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Dr K Koteswara Rao1,52,11,902 (21.89%)Shareholding of Promoter and Promoter Group
Kollipara Nirmala11,92,000 (1.72%)Shareholding of Promoter and Promoter Group
Kollipara Srinivas24,000 (0.03%)Shareholding of Promoter and Promoter Group

About TRANSGENE BIOTEK LTD.

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company i

Parent Organisation

Indian Private

NSE Symbol

TRANSGENE BIOTEK LTD.

Founded

1990

TRANSGENE BIOTEK LTD. CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

ITDC

INDIA TOURISM DEVELOPMENT CORP

703.55
+117.25 (+20%)
SHAREINDIA

SHARE IND. SECURITIES LTD

164.91
+27.48 (+20%)
ZSARACOM

SARASWATI COMM (INDIA) L

12404
+2067 (+20%)
ZSARACOM

SARASWATI COMMERCIAL (INDIA) L

12759.45
+2126.55 (+20%)
View all

Top gainers

HCLTECH

HCL TECHNOLOGIES LTD

1168.2
+34.00 (+3.00%)
TECHM

TECH MAHINDRA LIMITED

1447.5
+41.00 (+2.92%)
INFY

INFOSYS LIMITED

1071.8
+29.60 (+2.84%)
TITAN

TITAN COMPANY LIMITED

4604.2
+119.80 (+2.67%)
View all

Top losers

TRENT

TRENT LTD

2927.8
-416.00 (-12.44%)
ADANIENT

ADANI ENTERPRISES LIMITED

3107.2
-99.40 (-3.10%)
ADANIPORTS

ADANI PORT & SEZ LTD

1833.9
-30.50 (-1.64%)
BEL

BHARAT ELECTRONICS LTD

419.15
-6.40 (-1.50%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)